PT  - JOURNAL ARTICLE
AU  - Hu, Zixin
AU  - Ge, Qiyang
AU  - Li, Shudi
AU  - Xu, Tao
AU  - Boerwinkle, Eric
AU  - Jin, Li
AU  - Xiong, Momiao
TI  - Spread of Covid-19 in the United States is controlled
AID  - 10.1101/2020.05.04.20091272
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.04.20091272
4099  - http://medrxiv.org/content/early/2020/05/11/2020.05.04.20091272.short
4100  - http://medrxiv.org/content/early/2020/05/11/2020.05.04.20091272.full
AB  - As of May 1, 2020, the number of cases of Covid-19 in the US passed 1,062,446, interventions to slow down the spread of Covid-19 curtailed most social activities. Meanwhile, an economic crisis and resistance to the strict intervention measures are rising. Some researchers proposed intermittent social distancing that may drive the outbreak of Covid-19 into 2022. Questions arise about whether we should maintain or relax quarantine measures. We developed novel artificial intelligence and causal inference integrated methods for real-time prediction and control of nonlinear epidemic systems. We estimated that the peak time of the Covid-19 in the US would be April 24, 2020 and its outbreak in the US will be over by the end of July and reach 1,551,901 cases. We evaluated the impact of relaxing the current interventions for reopening economy on the spread of Covid-19. We provide tools for balancing the risks of workers and reopening economy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr. Li Jin was partially supported by National Natural Science Foundation of China 91846302Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is published by CSSE at Johns Hopkins University at https://github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data https://github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data